A key drug is at the center of a debate over abortion access. Federal judges are weighing whether to tighten rules for prescribing this medication. The case is part of a broader effort to restrict abortion, which has been ongoing since a major court decision four years ago.

The US Food and Drug Administration is also reviewing its rules and may propose changes, suggesting that its process should take priority over court action. Further details about the case and its potential implications are available from the source, including information about related court cases and the current legal landscape surrounding abortion.